Teva Pharmaceutical Industries reported $20.84B in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbvie ABBV:US $ 63522M 667M
Aerie Pharmaceuticals AERI:US $ 311.68M 77.15M
ALKERMES ALKS:US 292.17M 633K
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 36010M 2788M
AstraZeneca AZN:LN 28805M 83M
Biogen BIIB:US $ 6275.7M 1.7M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Coherus Biosciences CHRS:US $ 420.46M 11.68M
Eli Lilly And LLY:US $ 15152.9M 193.5M
Emergent Biosolutions EBS:US $ 801.5M 7.9M
Endo International Ordinary Shares ENDP:US $ 8057.5M 9.85M
Gilead Sciences GILD:US $ 25183M 4M
GlaxoSmithKline GSK:LN 29226M 8654M
Henry Schein HSIC:US $ 773M 38.35M
Horizon Pharma HZNP:US $ 2552.74M 2.49M
JAZZ PHA JAZZ:US $ 5992.87M 32.34M
Lannett LCI:US $ 610.08M 6.6M
Merk MRK:US $ 30586M 104M
Novartis NOVN:VX SF 24373M 150M
Pacira Pharmaceuticals PCRX:US $ 729.74M 55.21M
Perrigo Ordinary Shares PRGO:US $ 3510.6M 593.9M
Pfizer PFE:US $ 35656M 539M
Phibro Animal Health PAHC:US $ 400.62M 13.3M
Revance Therapeutics RVNC:US $ 430.86M 150.23M
Supernus Pharmaceuticals SUPN:US $ 400.38M 21.13M
Takeda 4502:JP Y 4141418M 90521M
Teva Pharmaceutical Industries TEVA:US $ 20840M 777M
Xeris Pharmaceuticals Inc XERS:US $ 137.64M 49.57M
Zoetis ZTS:US $ 5228M 1364M